Transjugular Intrahepatic Porto Systemic Shunt for Hepatorenal Syndrome in Alcoholic Patients.
作者信息
Testino Gianni
机构信息
Unit of Addiction and Hepatology, Alcohological Regional Centre, ASL3 c/o Ospedale Policlinico San Martino, Genoa, Italy.
出版信息
Dig Dis Sci. 2021 Jan;66(1):325-326. doi: 10.1007/s10620-020-06243-0. Epub 2020 Apr 13.
PMID:32285320
Abstract
摘要
相似文献
1
Transjugular Intrahepatic Porto Systemic Shunt for Hepatorenal Syndrome in Alcoholic Patients.
Dig Dis Sci. 2021 Jan;66(1):325-326. doi: 10.1007/s10620-020-06243-0. Epub 2020 Apr 13.
2
Transjugular intrahepatic portosystemic shunt for hepatorenal syndrome: A systematic review and meta-analysis.
Dig Liver Dis. 2018 Apr;50(4):323-330. doi: 10.1016/j.dld.2018.01.123. Epub 2018 Feb 17.
3
Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome.
Lancet. 1997 Mar 8;349(9053):697-8. doi: 10.1016/s0140-6736(97)24010-9.
4
Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Hepatogastroenterology. 2003 Nov-Dec;50(54):1753-5.
5
Hepatorenal syndrome.
Ann Hepatol. 2003 Jan-Mar;2(1):23-9.
6
Sequential treatment of hepatorenal syndrome and posthepatic cirrhosis by intrahepatic portosystemic shunt (TIPSS) and liver transplantation.
Hepatogastroenterology. 1995 Nov-Dec;42(6):985-7.
7
8
Transjugular Intrahepatic Portosystemic Shunts for Hepatorenal Syndrome: TIPping the Scales in Whose Favor?
Dig Dis Sci. 2020 Nov;65(11):3069-3071. doi: 10.1007/s10620-020-06351-x.
9
[Treatment of hepatorenal syndrome in liver cirrhosis].
Dtsch Med Wochenschr. 2000 Jun 2;125(22):712-3.
10
Transjugular intrahepatic portosystemic stent shunt for hepatorenal syndrome and ascites.
Digestion. 1998 Jul;59 Suppl 2:41-4. doi: 10.1159/000051419.
本文引用的文献
1
Inpatient Mortality Benefit with Transjugular Intrahepatic Portosystemic Shunt for Hospitalized Hepatorenal Syndrome Patients.
Dig Dis Sci. 2020 Nov;65(11):3378-3388. doi: 10.1007/s10620-020-06136-2. Epub 2020 Feb 15.
2
Management of end-stage alcohol-related liver disease and severe acute alcohol-related hepatitis: position paper of the Italian Society on Alcohol (SIA).
Dig Liver Dis. 2020 Jan;52(1):21-32. doi: 10.1016/j.dld.2019.09.017. Epub 2019 Nov 19.
3
Severe acute alcoholic hepatitis and hepatorenal syndrome: role of transjugular intrahepatic portosystemic stent shunt.
J Med Life. 2012 Jun 12;5(2):203-5. Epub 2012 Jun 18.
4
5
Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Hepatogastroenterology. 2003 Nov-Dec;50(54):1753-5.
Zotero 插件